Therasid Bioscience
PrivateLast Round
Series B
Jun 1, 2022
Total Funding Raised
$18.48M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Therasid Bioscience operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Series B round in June 2022.
Therasid Bioscience is a biotechnology company that develops innovative first-in-class drugs for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Therasid Bioscience Comparables
Compare Therasid Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| JD Bioscience | 89% | |
| OrsoBio | 85% | |
| J2H Biotech | 84% |
For institutional investors. Book with your work email.
Therasid Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 1, 2022 | ||||
| Debt | Nov 1, 2020 | ||||
| Series A | Jul 1, 2019 |
For institutional investors. Book with your work email.
Therasid Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BSK Investment | Series A |
| Kiwoom Investment | Debt |
| Tigris Investment | Debt |
| AJU IB Investment | Debt, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 354% MoM.
- Jun 18, 2026
Monthly visitors increased 509% MoM.
For institutional investors. Book with your work email.
Therasid Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Therasid Bioscience's valuation, stock price, and market status.
Is Therasid Bioscience a public or private company?
Therasid Bioscience is a private company.
What is the current stock price of Therasid Bioscience?
Therasid Bioscience is a private company, so its shares have no public market price. Caplight tracks Therasid Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Therasid Bioscience worth (valuation)?
Valuation information for Therasid Bioscience is not publicly available.
Can I buy Therasid Bioscience stock?
Therasid Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Therasid Bioscience's last funding round?
Therasid Bioscience's most recent funding round was Series B on June 1, 2022.
Who are the main investors in Therasid Bioscience?
Key investors in Therasid Bioscience include BSK Investment, Kiwoom Investment, Tigris Investment, AJU IB Investment.
Will Therasid Bioscience IPO soon?
No public IPO plans have been announced for Therasid Bioscience.
How can I track Therasid Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Therasid Bioscience's shares on secondary markets.